Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
83.60
-0.21 (-0.25%)
Apr 29, 2026, 9:34 AM EDT - Market open
Nektar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 2,821 | 860 | 172 | 108 | 425 | 2,493 | |
| Market Cap Growth | 2352.91% | 401.35% | 59.16% | -74.63% | -82.96% | -18.24% | |
| Enterprise Value | 2,731 | 757 | 129 | -20 | 179 | 1,866 | |
| Last Close Price | 83.81 | 42.28 | 13.95 | 8.47 | 33.90 | 202.65 | |
| PS Ratio | 51.20 | 15.57 | 1.74 | 1.20 | 4.61 | 24.47 | |
| PB Ratio | 19.01 | 9.57 | 2.82 | 0.82 | 1.16 | 3.67 | |
| P/TBV Ratio | 31.48 | 9.57 | 2.82 | 0.82 | 1.46 | 4.14 | |
| EV/Sales Ratio | 49.45 | 13.70 | 1.31 | - | 1.94 | 18.31 | |
| Debt / Equity Ratio | 1.66 | 1.66 | 3.20 | 1.76 | 0.78 | 0.50 | |
| Net Debt / Equity Ratio | -1.08 | -1.08 | -1.23 | -0.76 | -0.59 | -0.68 | |
| Net Debt / EBITDA Ratio | 0.75 | 0.75 | 0.60 | 0.78 | 0.96 | 1.07 | |
| Net Debt / FCF Ratio | 0.46 | 0.46 | 0.42 | 0.51 | 0.70 | 1.08 | |
| Asset Turnover | 0.19 | 0.19 | 0.28 | 0.16 | 0.10 | 0.08 | |
| Inventory Turnover | - | - | - | 1.91 | 1.24 | 1.60 | |
| Quick Ratio | 4.62 | 4.62 | 4.18 | 5.97 | 7.53 | 8.90 | |
| Current Ratio | 4.97 | 4.97 | 4.26 | 6.45 | 8.01 | 9.34 | |
| Return on Equity (ROE) | -217.94% | -217.94% | -124.10% | -110.95% | -70.39% | -59.64% | |
| Return on Assets (ROA) | -27.98% | -27.98% | -23.14% | -15.25% | -16.43% | -21.00% | |
| Return on Invested Capital (ROIC) | - | - | -450.92% | -131.09% | -111.04% | -137.22% | |
| Return on Capital Employed (ROCE) | -57.60% | -57.60% | -53.60% | -39.00% | -37.40% | -43.20% | |
| Earnings Yield | -5.80% | -19.08% | -69.35% | -256.12% | -86.68% | -21.01% | |
| FCF Yield | -7.40% | -24.34% | -103.28% | -179.50% | -72.91% | -17.15% | |
| Buyback Yield / Dilution | -23.05% | -23.05% | -8.24% | -1.53% | -2.10% | -2.64% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.